NICE to assess cancer and heart treatments next
The National Institute for Clinical Excellence's next work programme will consider of treatments for cancer and heart disease. Thrombolytic drugs for heart attacks, caelyx for ovarian cancer and STI-571 for chronic myeloid leukaemia will be appraised. Other treatments NICE will consider in the next wave will include surgical procedures for obesity and computerised cognitive behaviour therapy for people with anxiety and depression. It will also extend its evaluation of the rheumatoid ...
Register now for free to view this page
Please register now to access this content
This content is for registered users only
To check that you are registered please enter your email address below
Not registered?
Registration is simple and quick. By registering you will be able to read selected articles on HSJ.co.uk, PLUS sign up to HSJ email newsletters straight away.
